Gilenya

Biogen's MS Pill Roars Out Of Launch Gate

Biogen's MS Pill Roars Out Of Launch Gate

TheStreet.com

Overnight success proves elusive for oral MS drugs

Overnight success proves elusive for oral MS drugs

Fierce Pharma

Battle Lines Drawn in the MS Market

Battle Lines Drawn in the MS Market

Motley Fool

JAMA says FDA jumped the gun on Gilenya, Pradaxa

JAMA says FDA jumped the gun on Gilenya, Pradaxa

Fierce Pharma

Your Warning Label Is My Sales Brochure

Your Warning Label Is My Sales Brochure

Motley Fool

New Caution Urged Over Sole Oral MS Drug On the Market

New Caution Urged Over Sole Oral MS Drug On the Market

WSJ Online

Novartis limits use of Copaxone rival Gilenya

Novartis limits use of Copaxone rival Gilenya

Globes, Israel

Novartis MS Patient Develops Rare Brain Disease

Novartis MS Patient Develops Rare Brain Disease

Pharmalot

Watchdog says FDA should consider restricting Gilenya

Watchdog says FDA should consider restricting Gilenya

Fierce Pharma